These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30218298)

  • 1. Risk factors for kidney disease among HIV-1 positive persons in the methadone program.
    Matłosz B; Pietraszkiewicz E; Firląg-Burkacka E; Grycner E; Horban A; Kowalska JD
    Clin Exp Nephrol; 2019 Mar; 23(3):342-348. PubMed ID: 30218298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nevirapine induces abstinence symptoms in patients on a methadone maintenance program with HIV infection].
    Baño Rodrigo MD; Agujetas Rodríguez M; López García ML; Guillén Llera JL
    Rev Clin Esp; 2000 Jan; 200(1):12-4. PubMed ID: 10721283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).
    Shrestha R; Copenhaver MM
    Addict Behav; 2018 Oct; 85():88-93. PubMed ID: 29879611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme.
    Zhao Y; Shi CX; McGoogan JM; Rou K; Zhang F; Wu Z
    Addiction; 2015 Jan; 110 Suppl 1(Suppl 1):40-50. PubMed ID: 25533863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in Renal Function among HIV-Infected Koreans Receiving Tenofovir Disoproxil Fumarate-Backbone Antiretroviral Therapy: A 3-Year Follow-Up Study.
    Lee KH; Lee JU; Ku NS; Jeong SJ; Han SH; Choi JY; Song YG; Kim JM
    Yonsei Med J; 2017 Jul; 58(4):770-777. PubMed ID: 28540990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients.
    Huang YS; Chan CK; Tsai MS; Lee KY; Lin SW; Chang SY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2017 Oct; 50(5):595-603. PubMed ID: 26514942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of an effect of atazanavir on steady-state pharmacokinetics of methadone in patients chronically treated for opiate addiction.
    Friedland G; Andrews L; Schreibman T; Agarwala S; Daley L; Child M; Shi J; Wang Y; O'Mara E
    AIDS; 2005 Oct; 19(15):1635-41. PubMed ID: 16184033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of renal adverse effects of combination anti-retroviral therapy including tenofovir in HIV-infected patients.
    Tanaka H; Arai M; Tomoda Y; Wada T; Yago K; Satoh M
    J Pharm Pharm Sci; 2013; 16(3):405-13. PubMed ID: 24021289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a switch from tenofovir- to abacavir-based antiretroviral therapy, with or without atazanavir, on renal function.
    Guillemi SA; Ling SH; Dahlby JS; Yip B; Zhang W; Hull MW; Lima VD; Hogg RS; Werb R; Montaner JS; Harris M
    J Int AIDS Soc; 2016; 19(1):20995. PubMed ID: 27624144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohort.
    Postorino MC; Prosperi M; Focà E; Quiros-Roldan E; Di Filippo E; Maggiolo F; Borghetti A; Ladisa N; Di Pietro M; Gori A; Sighinolfi L; Pan A; Mazzini N; Torti C
    BMC Infect Dis; 2017 Mar; 17(1):212. PubMed ID: 28298195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone.
    Altice FL; Friedland GH; Cooney EL
    AIDS; 1999 May; 13(8):957-62. PubMed ID: 10371177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The medical management of opioid dependence in HIV primary care settings.
    Lum PJ; Tulsky JP
    Curr HIV/AIDS Rep; 2006 Nov; 3(4):195-204. PubMed ID: 17089480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG; Engsig FN; Feldt-Rasmussen B; Kirk O; Kronborg G; Pedersen C; Gerstoft J; Obel N
    Scand J Infect Dis; 2012 Sep; 44(9):689-96. PubMed ID: 22680981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
    Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
    J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study.
    Roncero C; Fuster D; Palma-Álvarez RF; Rodriguez-Cintas L; Martinez-Luna N; Álvarez FJ
    AIDS Care; 2017 Dec; 29(12):1551-1556. PubMed ID: 28393548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    Kooij KW; Vogt L; Wit FWNM; van der Valk M; van Zoest RA; Goorhuis A; Prins M; Post FA; Reiss P;
    J Infect Dis; 2017 Sep; 216(6):622-631. PubMed ID: 28934420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals.
    Juega-Mariño J; Bonjoch A; Pérez-Alvarez N; Negredo E; Bayes B; Bonet J; Clotet B; Romero R
    Medicine (Baltimore); 2017 Sep; 96(37):e7421. PubMed ID: 28906351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and virological failure among HIV-infected people who inject drugs on antiretroviral treatment in China: An observational cohort study.
    Zhao Y; Zhang M; Shi CX; Huang J; Zhang F; Rou K; Wu Z
    Drug Alcohol Depend; 2017 Jan; 170():189-197. PubMed ID: 27987476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antiretroviral therapies by HIV-infected persons receiving methadone maintenance.
    Stein MD; Urdaneta ME; Clarke J; Maksad J; Sobota M; Hanna L; Markson LE
    J Addict Dis; 2000; 19(1):85-94. PubMed ID: 10772605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic- and gender-specific differences in the prevalence of HIV among patients in opioid maintenance treatment-a case register analysis.
    Liebrenz M; Stohler R; Nordt C
    Harm Reduct J; 2014 Aug; 11():23. PubMed ID: 25130184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.